Inventor · disambiguated record
Zhen Xu
Also filed as: XU ZHEN · Xu zhen-zhong
13 granted patents·9 pending applications·55 citations·filing 2011–2025
88Inventor score
Files withRESPIRA THERAPEUTICS INC15UNIV MICHIGAN REGENTS3JI RU-RONG1UNIV NORTH CAROLINA CHAPEL HILL1UNIV NORTH CAROLINA STATE1
Top patents by PatentIndex Score
22 records- 0193US10912778B2Methods for treatment of pulmonary hypertensionRESPIRA THERAPEUTICS INC·Filed 2017·Granted Feb 9, 2021·10 cites·17 claims
- 0290US11813485B2Systems and methods for histotripsy immunosensitizationUNIV MICHIGAN REGENTS·Filed 2021·Granted Nov 14, 2023·12 cites·25 claims
- 0385US9241991B2Agents, compositions, and methods for treating pruritus and related skin conditionsJI RU-RONG·Filed 2011·Granted Jan 26, 2016·29 cites·20 claims
- 0483US12364701B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·0 cites·33 claims
- 0582US2025332171A1Pde5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0679US12263174B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·19 claims
- 0777US11806314B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·0 cites·37 claims
- 0877US11491161B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2021·Granted Nov 8, 2022·0 cites·30 claims
- 0977US10525216B2Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2016·Granted Jan 7, 2020·3 cites·12 claims
- 1074US2025108180A1Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1174US2025195531A1Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1273US11911390B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·11 claims
- 1373US11491160B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2021·Granted Nov 8, 2022·0 cites·20 claims
- 1470US2016317542A1Pde5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1566US2024024705A1Systems and methods for histotripsy immunosensitizationUNIV MICHIGAN REGENTS·Filed 2023·Application pending·0 cites
- 1665US2023001114A1Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1760US10682476B2Powder inhaler, system and methodsRESPIRA THERAPEUTICS INC·Filed 2015·Granted Jun 16, 2020·1 cites·4 claims
- 1859US11471623B2Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2019·Granted Oct 18, 2022·0 cites·20 claims
- 1958US12116597B2Autophagy as a therapeutic target for intracranial aneurysmUNIV TEXAS·Filed 2022·Granted Oct 15, 2024·0 cites·16 claims
- 2050US2023329559A1Transcranial mr-guided histotripsy systems and methodsUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 2149US2025017608A1Sequencing and strategies for enhancing intravascular thrombus disruption with phase-change cavitation enhancing agentsUNIV NORTH CAROLINA STATE·Filed 2022·Application pending·0 cites
- 2248US2020405258A1Methods and systems for using phase change nanodroplets to enhance sonothrombolysisUNIV NORTH CAROLINA CHAPEL HILL·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhen Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →